Articles tagged with Sars Cov 2
Researchers at UC Davis Health have developed an engineered antibody, FuG1, that can interfere with the cell-to-cell transmission ability of SARS-CoV-2. The approach targets the furin enzyme, which is critical for viral transmissibility, and could be added to existing SARS-CoV-2 antibody cocktails.
A team of scientists has developed a three-dimensional airway model made from patient-derived stem cells to study COVID-19 infection. The model replicates the initial stages of infection and can be used to test potential antiviral drugs, with results showing that multi-ciliated airway cells are the primary entry point for the virus.
A clinical trial of niclosamide in COVID-19 patients found signals of benefit warranting further study. The medication showed potential in reducing contagiousness and symptoms, particularly in higher-risk populations.
A recent study published in Cell found that T cell responses are still robust against the Omicron variant in most individuals with prior SARS-CoV-2 infection or vaccination, offering protection against severe disease. Booster vaccines can enhance T cell responses, substantially increasing immunity against severe COVID-19.
Scientists sequenced the gene expression profiles of more than 170,000 individual cells to shed light on a key mystery: the role of Type I Interferons (IFN) during viral infections. The study reveals interferon plays a crucial role in clearing the virus by alerting immune cells, such as macrophages, to search and destroy infected cells.
Researchers detected SARS-CoV-2 in the exhaled breaths and coughs of individuals with COVID-19. The presence of virus RNA was mainly found in cough samples, but also in normal breaths and airway opening breaths.
Researchers examined Kappa and Delta variant structures using cryo-EM, finding Delta's spike protein binds stronger with human ACE2 receptor. This explains the rapid global dominance of the Delta variant. The study provides insight into COVID-19 variants' evolution.
Researchers examined factors associated with disease severity and outcomes in 167,000 US children infected with SARS-CoV-2. Children's age, sex, and underlying health conditions were linked to varying levels of disease severity.
A study by MedUni Vienna found that many cancer patients can build up sufficient immunity against SARS-CoV-2 after the third vaccination. However, patients with blood cancers may not develop protection due to immunosuppressive treatments.
Researchers attribute vaccine effectiveness to mutations shared with previous variants, resulting in relatively small severe cases and deaths among vaccinated patients. The study analyzed over 200,000 genomes and found identical mutations that could serve as targets for future vaccines.
A study of 14 high-risk children found that convalescent plasma provided expected antibody levels without safety concerns. The therapy's effectiveness declined over time, highlighting the need for early administration.
The IEEE forum identified four major challenges to address during the pandemic: healthcare, screening, tracing, and treatment. The panel highlighted socioeconomic and education status as critical factors impacting mortality rates and hospital admission lengths.
A recent NIH-funded study found that pregnant women with COVID-19 are at a greater risk for common pregnancy complications, including cesarean delivery and preterm birth. The study also highlighted the importance of vaccination to protect pregnant women and their babies.
A nationwide study led by University of Utah Health found that pregnant individuals infected with COVID-19 are about 40% more likely to develop serious complications or die during pregnancy than those who aren't infected. The severity of COVID-19 symptoms was a key indicator of heightened risk of pregnancy complications.
Researchers have identified a powerful combination of antivirals to treat COVID-19 by combining brequinar with remdesivir or molnupiravir. The combinations inhibited the SARS-CoV-2 virus in human respiratory cells and mice, suggesting increased potency compared to individual drugs.
The Rice team created an easily manufactured adhesive silicone harness that improves the fit of light surgical masks, making them comparable to N95 and KN95 masks in terms of aerosol droplet stopping. The revised design includes a wider harness along the nose slope for better sealing.
A study identified eleven natural compounds that inhibit SARS-CoV-2 main protease, a key player in viral replication and transcription. The virtual screening approach used to discover these compounds has implications for the development of new antiviral therapeutics.
A study found that severe COVID-19 is associated with endothelial dysfunction, strong inflammatory processes, and a dysfunctional immune system. The researchers discovered seven plasma proteins linked to severe disease, which are also involved in the regeneration of the endothelial barrier during recovery.
Researchers detect four cryptic variants of SARS-CoV-2 in NYC wastewater samples, suggesting possible animal origins. The variants' mutations could help identify the next variant of concern for COVID-19.
A team of researchers used wastewater-based epidemiology to detect SARS-CoV-2 in more areas of the Olympic village than clinical testing indicated. The study found that daily screenings missed asymptomatic and post-quarantine patients, highlighting the need for alternative methods.
A new Northwestern Medicine study found a probable variant of concern, eta, circulating in Nigeria in early 2021, but was grossly underreported globally. The study discovered that eta had characteristics of a variant of concern and outcompeted the alpha variant in West Africa.
The first US peer-reviewed study on omicron patient outcomes found significant differences in infection behavior. Ominron patients are significantly younger, have increased vaccine breakthrough rates, and are less likely to be hospitalized compared to patients with alpha or delta variants.
A study at a midwestern university examined the relationship between vaccine coverage and the transmission of SARS-CoV-2 variants during in-person learning. The results showed a correlation between higher vaccination rates and reduced spread of variants, highlighting the effectiveness of vaccines in mitigating COVID-19 transmission.
A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae. Researchers are exploring therapy using lung epithelial stem and progenitor cells to mitigate virus-induced inflammatory storm and promote tissue regeneration efficiently.
A study has identified specific signaling pathways that determine when immune cells develop into long-lived protective T cells. The researchers found a distinct molecular signature of these memory cells, which helps to unravel the complex way in which immunological memory is formed and maintained.
Research shows that mask mandates are effective in reducing COVID-19 transmission in rural US counties with lower population density. The study found a 16.9% reduction in cases after mask mandates were introduced.
Scientists have found evidence that carnosic acid in rosemary can block SARS-CoV-2 infection and reduce inflammation. The compound has been shown to inhibit the powerful inflammatory pathway active in severe COVID-19 and other diseases.
A computational study finds that Omicron's spike protein has evolved to evade multiple classes of antibodies targeting SARS-CoV-2, even those from vaccinated individuals and monoclonal antibody treatments. The study suggests vaccines still offer protection due to the development of T cell immunity.
The novel vaccine combines immune focusing and self-assembling nanoparticles to elicit a strong protective response. In animal studies, it showed higher levels of neutralizing antibodies than existing vaccines and protected mice from death in lethal challenge experiments.
A study by the University of Leeds found that changing drills from air-powered to electric drills can significantly reduce aerosol spray and create a safer environment for patients and dental teams. The research resulted in a 99.98% reduction in virus spread, potentially allowing millions more treatments to be carried out.
A new study aims to improve antibody responses in kidney and liver transplant recipients to COVID-19 mRNA vaccine doses, exploring the impact of reduced immunosuppressive medication. The CPAT-ISR trial will enroll up to 400 adults with a history of organ transplants and evaluate the effectiveness of this strategy.
Researchers found that current COVID-19 vaccines provide robust protection against severe disease caused by the Omicron variant through induced cellular immunity. The study showed that CD8+ T cell responses were over 80% cross-reactive with the original strain, suggesting a key role in vaccine protection.
A Dartmouth study reveals that consumers using at-home COVID-19 self tests may misinterpret the implications of their test results, leading to either unnecessary or inadequate quarantine. The study suggests that individuals at high risk for infection should still quarantine after a negative test result.
Researchers at MedUni Vienna have developed a new Covid-19 mouse model that can be used to study the disease mechanisms and develop effective treatments. The model uses viral mutations that enable efficient virus infection and replication in mice, allowing for the study of symptoms and potential therapies.
Scientists at UC Riverside and UCLA have engineered nanoparticles to serve as 'molecular traps' that bind to SARS-CoV-2, preventing it from attacking macrophages and inducing inflammation. The findings suggest potential therapeutic strategies for treating COVID-19-associated diseases.
A novel analysis applied to anonymous location information from mobile devices helped health officials stem community outbreaks and allocate testing resources. The study successfully predicted initial waves of cases, localized outbreaks, and areas of high transmission risk.
A Rutgers study found measurable airborne SARS-CoV-2 RNA in the air of most homes where COVID-19 infected individuals were isolating, suggesting airborne transmission beyond isolation rooms poses a risk to other occupants. The study also showed that infected individuals often did not strictly adhere to self-isolation protocols.
A Brazilian study found that SARS-CoV-2 can persist in patients for over a month before becoming negative on diagnostic tests. Researchers tracked 38 COVID-19 patients and found that the virus remained detectable in three cases for more than 70 days, raising concerns about quarantine periods.
Researchers developed a school simulation model that shows how the virus spreads in different settings and calculates the effectiveness of measures against its spread. The model reveals that elementary and lower secondary schools can keep reproduction rates below 1 with classroom ventilation, wearing masks, and class size reduction.
A large real-world study published by Israel's Clalit Research Institute found that parental vaccination with the BNT162b2 vaccine decreased the risk of infection for unvaccinated children by 58.1%, regardless of household size or child age. Vaccination also reduced transmission from infected parents to their unvaccinated children.
A recent study found that adding a booster dose of any COVID-19 vaccine to fully vaccinated adults elicits an immune response and is safe. The trial, sponsored by the NIAID, used 458 adults who received a full regimen of any EUA or approved COVID-19 vaccine.
A new portable $51 testing kit can provide fast and reliable COVID-19 detection in resource-poor regions, refugee camps, and disaster zones. The non-invasive saliva sampling system uses a technique similar to PCR testing, with costs comparable to commercial tests.
The Omicron variant diverged from previous variants through adaptive evolution, with more than 30 mutations in its spike protein. The team found evidence of positive natural selection and partial immune evasion contributing to its rapid spread.
Researchers at George Washington University have created a blood test that can identify COVID-19 infections and predict their severity. The test detects changes in neutrophil activity and T-cell response, which can help doctors determine the best treatment plan for patients.
Lab tests show current anti-COVID pills remain effective against omicron, but available antibody therapies are substantially less effective. Researchers tested various treatments and found that some antibodies have lost their ability to neutralize omicron at realistic dosages.
A team of researchers from Boston University School of Medicine has identified extracellular vimentin as an attachment factor facilitating SARS-CoV-2 entry into human endothelial cells. The study found that depletion of vimentin significantly reduces SARS-CoV-2 infection, while over-expression with ACE2 increases the infection rate.
Researchers have determined the precise structural changes in omicron's spike protein, which allows it to evade antibodies against previous variants. The findings provide a blueprint for designing new countermeasures, such as vaccines or therapeutics, against omicron and future coronavirus variants.
A new study finds that breakthrough infections following vaccination and natural infection followed by vaccination provide roughly equal levels of enhanced immune protection. Researchers at OHSU found that both groups generated greater levels of immunity compared to those who were vaccinated with no infection.
A new study reveals the Beta variant of SARS-CoV-2 can elicit a wide range of antibodies effective against both Delta and Omicron variants. The findings suggest that vaccination strategies could be improved by leveraging this broad immunity.
Researchers found a markedly increased risk of carditis associated with BNT162b2 vaccination, particularly in adolescents after the second dose. The study's findings highlight the need for refined vaccination strategies to balance risk and benefits across different sub-populations.
A new study reveals that the Omicron variant is sensitive to inhibition by the interferon response, an unspecific immune reaction present in all body cells. This provides the first explanation for why COVID-19 patients infected with Omicron are less likely to experience severe disease.
Four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize variants of concern, including Delta and Omicron. Fully vaccinated people have fewer memory B cells and neutralizing antibodies against the Omicron variant.
Researchers at the University of Hong Kong found that the Omicron variant is less effective in replicating cells and causing diseases than other COVID-19 variants. The study suggests that mutations in the spike protein may reduce its capacity to use a certain pathway, impairing its entry and replication.
A new study found that hospitalized children who tested positive for SARS-CoV-2 were more likely to develop neurological symptoms, including headache and altered mental status. The research also showed that these symptoms were more common in kids with MIS-C, a condition characterized by fever, inflammation, and organ dysfunction.
A UK study found that over a third of care home residents and a quarter of staff in England showed evidence of SARS-CoV-2 infection during the first two waves of the pandemic. The study also revealed that antibodies against the virus became undetectable in half of the population within eight months.
A recent study found that individuals vaccinated three times or those who were vaccinated after an earlier COVID-19 infection had comparable neutralizing antibody activity to those with a breakthrough case. The study suggests that repeated exposure to SARS-CoV-2 antigens enhances the quality of antibody responses.
Researchers are working tirelessly to develop vaccines against the Omicron variant, a crucial step in combating the pandemic. By understanding the biology of Omicron, scientists hope to create effective treatments and boosters to protect against future pandemics.
Researchers have identified several factors that can predict the development of long COVID, including the presence of certain autoantibodies, pre-existing Type 2 diabetes, and low cortisol levels. The study found that administering antivirals early in the disease course may also prevent some long COVID symptoms.
Researchers developed reference materials with known viral loads to standardize PCR test results. The study found that Ct values varied among labs, highlighting the need for reference materials to compare and standardize results.
A new study published in the Journal of the American Medical Association finds that those who received the Moderna COVID-19 mRNA vaccine have a lower risk of experiencing 'breakthrough' COVID-19 cases compared to recipients of the Pfizer-BioNTech mRNA vaccine. The study also found that Moderna recipients were less likely to be hospital...